Skip to main content

Molecular Pathology of Colorectal Cancer

  • Chapter
  • First Online:
Molecular Surgical Pathology
  • 2505 Accesses

Abstract

Colorectal cancer is one of the most intensively studied cancer types, partly because of its high prevalence but also because of the existence of precursor lesions, known as adenomas, which can be detected endoscopically and removed. Theoretically, removal of these adenomas would prevent most cases of colorectal cancer from developing. Characteristic morphological steps in the evolution of these precursor lesions have been elucidated at a molecular level and the adenoma–carcinoma sequence, as this has become known, is one of the classical examples of stepwise progression of cancer. Gaining this knowledge has been facilitated by the occurrence of a variety of forms of familial intestinal cancer, the molecular genetic background of which has been largely clarified. Apart from early detection of familial forms of colorectal cancer and its use in genetic counseling, until recently this knowledge has had little impact on the clinical management of colorectal cancer. Classical clinicopathological parameters remain the essential parameters determining how a colorectal patient will be treated. This has dramatically changed in the last five years. With drugs specifically targeting the EGF receptor having been shown effective in colorectal cancer, mechanisms responsible for resistance have been explored. The finding that KRAS-mutated cancers do not respond to anti-EGFR treatment has had a profound impact on clinical management and on molecular diagnostics of colorectal cancer. With new targeted drugs in the pipeline it is highly likely that companion diagnostics will go through a period of explosive development. In this chapter we will discuss the biology of intestinal mucosa and its disturbance in cancer. We will review cancer family syndromes and the impact of understanding these on a molecular level has had on our understanding of colorectal cancer. Finally we will review how molecular diagnostics now contribute to the clinical management of colorectal cancer and what can be expected in this field in the near future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Readings

  • Bohanes P, LaBonte MJ, Winder T, Lenz HJ. Predictive molecular classifiers in colorectal cancer. Semin Oncol. 2011;38:576–87.

    Article  PubMed  CAS  Google Scholar 

  • Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138:2073–87.

    Article  PubMed  CAS  Google Scholar 

  • Bosch LJ, Carvalho B, Fijneman RJ, et al. Molecular tests for colorectal cancer screening. Clin Colorectal Cancer. 2011;10:8–23.

    Article  PubMed  CAS  Google Scholar 

  • Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. Lyon: IARC Press; 2010.

    Google Scholar 

  • van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–60.

    Article  PubMed  Google Scholar 

  • Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759–67.

    Article  PubMed  CAS  Google Scholar 

  • Gala M, Chung DC. Hereditary colon cancer syndromes. Semin Oncol. 2011;38:490–9.

    Article  PubMed  Google Scholar 

  • Kelley RK, Venook AP. Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling? Clin Colorectal Cancer. 2011;10:73–80.

    Article  PubMed  CAS  Google Scholar 

  • Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–70.

    Article  PubMed  CAS  Google Scholar 

  • Liang JJ, Alrawi S, Tan D. Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma. Int J Clin Exp Pathol. 2008;1:317–24.

    PubMed  CAS  Google Scholar 

  • Migliore L, Migheli F, Spisni R, Coppede F. Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol. 2011;2011:792362.

    Article  PubMed  Google Scholar 

  • Merlos–Suárez A, Barriga FM, Jung P, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 2011;8:511–24.

    Article  PubMed  Google Scholar 

  • Roth AD, Tejpar S, Delorenzi M, et al. Prognostic role of KRAS and BRAF in Stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial. J Clin Oncol. 2009;28:466–74.

    Article  PubMed  Google Scholar 

  • Sato T, van Es JH, Snippert HJ, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–8.

    Article  PubMed  CAS  Google Scholar 

  • Scoville DH, Sato T, He XC, Li L. Current view: intestinal stem cells and signaling. Gastroenterology. 2008;134:849–64.

    Article  PubMed  CAS  Google Scholar 

  • Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42:1–10.

    Article  PubMed  Google Scholar 

  • Vries RG, Huch M, Clevers H. Stem cells and cancer of the stomach and intestine. Mol Oncol. 2010;4:373–84.

    Article  PubMed  Google Scholar 

  • Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J Gastroenterol. 2008;14:378–89.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bosman, F.T. (2013). Molecular Pathology of Colorectal Cancer. In: Cheng, L., Eble, J. (eds) Molecular Surgical Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4900-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4900-3_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4899-0

  • Online ISBN: 978-1-4614-4900-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics